Advancements in new hepatitis C treatments

June 3, 2016

Hepatitis C is the leading blood-borne disease in the U.S., with more than 3.5 million people developing a chronic infection. While the outlook for treating hepatitis C was grim just a few years ago, now most patients can be cured with direct-acting antiviral medications, many of them evaluated at the UT Health Science Center San Antonio.




Health leaders welcome FDA action on e-cigarettes

May 6, 2016

Action by the U.S. Food and Drug Administration (FDA) May 5 to regulate e-cigarettes and vaping in the same way as cigarettes and smokeless tobacco is “a welcome step toward reducing the nation’s cancer burden,” said Ian M. Thompson Jr., M.D., director of the Cancer Therapy & Research Center (CTRC) at the Health Science Center. […]

e-cigarette